Challenges In The Management Of Medication-Related Osteonecrosis Of The Jaws - From Conservative To Surgical Treatment.

Claudio Freire SESSENTA JUNIOR,Maria Carmen Pereira SILVA,Kariana Wan-Dall GONÇALVES,Vanessa EISFIELD,José Luis DISSENHA,Laurindo Moacir SASSI,Juliana Lucena SCHUSSEL
DOI: https://doi.org/10.1016/j.oooo.2023.12.033
2024-06-07
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Abstract:Medication-related osteonecrosis of the jaws (MRONJ) is defined as exposed bone persisting for more than 8 weeks in patients who have been treated with antiresorptive or antiangiogenic agents and without a history of radiation therapy or jaw metastases. Treatment is challenging and includes both conservative and surgical measures, as demonstrated in this report. A 71-year-old patient diagnosed with metastatic breast cancer was using zoledronic acid. She was referred because of exposed bone in the mandible involving implants installed prior to oncologic treatment, with episodes of suppuration and associated symptomatology.
dentistry, oral surgery & medicine
What problem does this paper attempt to address?